Physician profile
Christopher Eric Cheng
NPI 1194228957
$2,328.96
in general payments reported to CMS, 2019-2025
12 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.10 · 2023: $1,404 · 2024: $374 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338 · Travel and Lodging: $752 · Education: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.04 |
| Travel and Lodging | $751.85 |
| Education | $214.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,151.60 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $437.70 | 2022-2024 | |
| Axsome Therapeutics, INC. | $212.44 | 2024-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $186.77 | 2023-2025 | Lumryz |
| Harmony Biosciences LLC | $114.98 | 2023-2025 | Wakix |
| Baxter Healthcare | $60.78 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Lilly USA, LLC | $39.58 | 2025 | Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.99 | 2024 | Ofev |
| Azurity Pharmaceuticals, INC. | $29.40 | 2023-2024 | Horizant, Horizant |
| Stryker Corporation | $24.53 | 2023 | T2 Alpha |
| Amgen INC. | $24.25 | 2024 | Uplizna |
| Genzyme Corporation | $16.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.